New drugs in the treatment of acute myeloid leukaemia

被引:0
|
作者
S. Kayser
Richard F. Schlenk
机构
[1] University Hospital of Ulm,Department of Internal Medicine III
关键词
Acute myeloid leukaemia; molecular tailored therapy; drug resistance modifiers; farnesyltransferase inhibitors; tyrosine kinase inhibitors;
D O I
10.1007/s12254-009-0108-8
中图分类号
学科分类号
摘要
引用
收藏
页码:75 / 79
页数:4
相关论文
共 50 条
  • [1] New drugs in the treatment of acute myeloid leukaemia
    Kayser, S.
    Schlenk, R. F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) : 75 - 79
  • [2] New drugs approved for acute myeloid leukaemia in 2018
    Kucukyurt, Selin
    Eskazan, Ahmet Emre
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (12) : 2689 - 2693
  • [3] Acute myeloid leukaemia drugs market
    Sorcha Cassidy
    Basharut A. Syed
    Nature Reviews Drug Discovery, 2016, 15 : 527 - 528
  • [4] Acute myeloid leukaemia drugs market
    Cassidy, Sorcha
    Syed, Basharut A.
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (08) : 527 - 528
  • [6] New trends in the treatment of adult acute myeloid leukaemia
    Willemze, R
    Suciu, S
    Mandelli, F
    deWitte, T
    Amadori, S
    Hayat, M
    Petti, MC
    Solbu, G
    Zittoun, R
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : S7 - S14
  • [7] Treatment of childhood acute myeloid leukaemia
    Taub, JW
    Ravindranath, Y
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (01): : 129 - 146
  • [8] The cost of treatment of acute myeloid leukaemia
    Grigoropoulos, N. F.
    Keidan, A. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 41 - 41
  • [9] Combination treatment for acute myeloid leukaemia
    Tanday, Sanjay
    LANCET ONCOLOGY, 2012, 13 (12): : E524 - E524
  • [10] Treatment of Relapsed Acute Myeloid Leukaemia
    Kell, Jonathan
    REVIEWS ON RECENT CLINICAL TRIALS, 2006, 1 (02) : 103 - 111